Cookies help us run our site more efficiently.

By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information or to customize your cookie preferences.

Is leaving dog poo in the street really so bad? The science says it’s even worse than you think

News Feed
Tuesday, June 20, 2023

ShutterstockWhat’s that smell? Is that what you think it is? You check your shoes and, sure enough, one is adorned with a sticky, foul-smelling patty of fresh wrongness. You have stepped in a landmine of the canine variety. We’ve all been there, and we all know footpaths, nature strips, parks, playing fields and front lawns are not good places for dog poo to sit. Yet, our streets and parks continue to be littered with dog poo. And with the pandemic driving a surge in dog ownership, anecdotal reports suggest the dog poo problem has grown only worse in recent years. Beyond the obvious unsightliness and the likelihood of making unwanted contact with dog poo, there are some other important reasons to pick up after dogs. Here’s what you need to know and what the science says about common efforts to deter dogs from pooping on your yard. Best to bag it and bin it. Shutterstock Read more: Is my dog too cold? How cold is too cold for a walk? Here's how to tell Dog poo is linked to illness, pollution and antibiotic resistance Dog faeces may contain microorganisms that cause illness in humans such as Salmonella, E. coli, Giardia and internal parasites. Dog poo can also be a potential reservoir for antibiotic-resistant bacteria, meaning humans could develop bacterial infections that are difficult to treat through contact with dog faeces. A recent Sydney study also identified dog faeces washed into storm water as a significant contributor to water pollution. This topic, in spite of its relevance and impact, has received little attention from scientists. Thankfully, however, we have a few brave souls who can say they have studied dog crap for the betterment of humanity. This research has revealed some patterns in where dog faeces is found in public. Dog poo can be a potential reservoir for antibiotic-resistant bacteria. Shutterstock Where is the dog poo problem more common? Dog fouling is significantly more common in parks where dogs are allowed off-leash, and areas close to car parks. The way dog walkers have traditionally used an area may also be an important factor, with one UK study noting: availability of bins, path morphology, visibility, and path location are key factors in determining the occurrence of dog faeces. The same study noted that while most dog walkers do the right thing, some are too “proud to pick up”, while others make contextual judgements about where and when it could be permissible to leave dog waste. Yet others are “disengaged” dog walkers, who “will not pick up even if they are aware of the health and environmental consequences”. Other research has suggested targeting keeping dogs on-leash between car parks and off-leash areas and providing waste disposal stations on popular dog-walking routes. This doesn’t help if you have a neighbour who lets their dog out to relieve themselves on the nature strip (or your yard), or people who walk their dogs without carrying waste disposal bags. And we all love the ones who bag the poop but leave the bag tied to a fence or by a gate. What about the old water-bottles-on-the grass trick? Dog owners who don’t pick up after their dog can be fined, but it can be hard to catch them in the act, and reporting a neighbour to authorities can often lead to ongoing hostility. Bottles of water on the grass is a time-honoured strategy to deter dogs, but there is no evidence this is effective and no clear reason why it would be. Dogs sometimes like to circle and find just the right spot to go, so they may prefer an area that has fewer obstacles to negotiate. Perhaps a yard bristling with lawn ornaments would enjoy some protection. (Interestingly, science suggests dogs may circle around like this to align their body to face north.) There are commercially available dog deterrents, but little evidence they are effective and under what conditions. Some believe any strong scent may deter an animal with a very strong sense of smell from lingering long enough to take a dump. But scent travels, so heavy and repeated applications would likely be needed (and this strategy could have unintended side effects on native urban ecosystems). Most dog walkers do the right thing. Shutterstock Educating dog walkers is key Aside from providing bags and a bin and enforcing leash laws particularly around carparks close to off-leash areas, research suggests education does help. Messages emphasising that good neighbours and members of the community diligently pick up after their dogs may be most effective, as people are responsive to social messages. If you have tried to appeal to your neighbour’s sense of community to no avail, and you’re not keen on a front yard bristling with garden gnomes and flamingos or drenched in possible dog-deterring chemicals, you could try providing bags and a sign promising surveillance. For all the dog owners out there that do pick up after their dogs, your community thanks you. The best way to dispose of dog faeces is in the bin. Composting requires high temperatures to neutralise the nasties in dog poop, and home composts are unlikely to get hot enough. And burying it simply allows these microorganisms to build up in the soil. Read more: Is your dog happy? Ten common misconceptions about dog behaviour Melissa Starling does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

And what about the old water-bottles-on-the grass trick? Does that actually work?

Shutterstock

What’s that smell? Is that what you think it is? You check your shoes and, sure enough, one is adorned with a sticky, foul-smelling patty of fresh wrongness. You have stepped in a landmine of the canine variety.

We’ve all been there, and we all know footpaths, nature strips, parks, playing fields and front lawns are not good places for dog poo to sit.

Yet, our streets and parks continue to be littered with dog poo. And with the pandemic driving a surge in dog ownership, anecdotal reports suggest the dog poo problem has grown only worse in recent years.

Beyond the obvious unsightliness and the likelihood of making unwanted contact with dog poo, there are some other important reasons to pick up after dogs.

Here’s what you need to know and what the science says about common efforts to deter dogs from pooping on your yard.

Best to bag it and bin it. Shutterstock

Read more: Is my dog too cold? How cold is too cold for a walk? Here's how to tell


Dog poo is linked to illness, pollution and antibiotic resistance

Dog faeces may contain microorganisms that cause illness in humans such as Salmonella, E. coli, Giardia and internal parasites.

Dog poo can also be a potential reservoir for antibiotic-resistant bacteria, meaning humans could develop bacterial infections that are difficult to treat through contact with dog faeces.

A recent Sydney study also identified dog faeces washed into storm water as a significant contributor to water pollution.

This topic, in spite of its relevance and impact, has received little attention from scientists. Thankfully, however, we have a few brave souls who can say they have studied dog crap for the betterment of humanity.

This research has revealed some patterns in where dog faeces is found in public.

Dog poo can be a potential reservoir for antibiotic-resistant bacteria. Shutterstock

Where is the dog poo problem more common?

Dog fouling is significantly more common in parks where dogs are allowed off-leash, and areas close to car parks.

The way dog walkers have traditionally used an area may also be an important factor, with one UK study noting:

availability of bins, path morphology, visibility, and path location are key factors in determining the occurrence of dog faeces.

The same study noted that while most dog walkers do the right thing, some are too “proud to pick up”, while others make contextual judgements about where and when it could be permissible to leave dog waste. Yet others are “disengaged” dog walkers, who “will not pick up even if they are aware of the health and environmental consequences”.

Other research has suggested targeting keeping dogs on-leash between car parks and off-leash areas and providing waste disposal stations on popular dog-walking routes.

This doesn’t help if you have a neighbour who lets their dog out to relieve themselves on the nature strip (or your yard), or people who walk their dogs without carrying waste disposal bags.

And we all love the ones who bag the poop but leave the bag tied to a fence or by a gate.

What about the old water-bottles-on-the grass trick?

Dog owners who don’t pick up after their dog can be fined, but it can be hard to catch them in the act, and reporting a neighbour to authorities can often lead to ongoing hostility.

Bottles of water on the grass is a time-honoured strategy to deter dogs, but there is no evidence this is effective and no clear reason why it would be.

Dogs sometimes like to circle and find just the right spot to go, so they may prefer an area that has fewer obstacles to negotiate. Perhaps a yard bristling with lawn ornaments would enjoy some protection. (Interestingly, science suggests dogs may circle around like this to align their body to face north.)

There are commercially available dog deterrents, but little evidence they are effective and under what conditions.

Some believe any strong scent may deter an animal with a very strong sense of smell from lingering long enough to take a dump. But scent travels, so heavy and repeated applications would likely be needed (and this strategy could have unintended side effects on native urban ecosystems).

Most dog walkers do the right thing. Shutterstock

Educating dog walkers is key

Aside from providing bags and a bin and enforcing leash laws particularly around carparks close to off-leash areas, research suggests education does help.

Messages emphasising that good neighbours and members of the community diligently pick up after their dogs may be most effective, as people are responsive to social messages.

If you have tried to appeal to your neighbour’s sense of community to no avail, and you’re not keen on a front yard bristling with garden gnomes and flamingos or drenched in possible dog-deterring chemicals, you could try providing bags and a sign promising surveillance.

For all the dog owners out there that do pick up after their dogs, your community thanks you.

The best way to dispose of dog faeces is in the bin. Composting requires high temperatures to neutralise the nasties in dog poop, and home composts are unlikely to get hot enough. And burying it simply allows these microorganisms to build up in the soil.


Read more: Is your dog happy? Ten common misconceptions about dog behaviour


The Conversation

Melissa Starling does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.

Read the full story here.
Photos courtesy of

AI accelerates problem-solving in complex scenarios

A new, data-driven approach could lead to better solutions for tricky optimization problems like global package routing or power grid operation.

While Santa Claus may have a magical sleigh and nine plucky reindeer to help him deliver presents, for companies like FedEx, the optimization problem of efficiently routing holiday packages is so complicated that they often employ specialized software to find a solution. This software, called a mixed-integer linear programming (MILP) solver, splits a massive optimization problem into smaller pieces and uses generic algorithms to try and find the best solution. However, the solver could take hours — or even days — to arrive at a solution. The process is so onerous that a company often must stop the software partway through, accepting a solution that is not ideal but the best that could be generated in a set amount of time. Researchers from MIT and ETH Zurich used machine learning to speed things up. They identified a key intermediate step in MILP solvers that has so many potential solutions it takes an enormous amount of time to unravel, which slows the entire process. The researchers employed a filtering technique to simplify this step, then used machine learning to find the optimal solution for a specific type of problem. Their data-driven approach enables a company to use its own data to tailor a general-purpose MILP solver to the problem at hand. This new technique sped up MILP solvers between 30 and 70 percent, without any drop in accuracy. One could use this method to obtain an optimal solution more quickly or, for especially complex problems, a better solution in a tractable amount of time. This approach could be used wherever MILP solvers are employed, such as by ride-hailing services, electric grid operators, vaccination distributors, or any entity faced with a thorny resource-allocation problem. “Sometimes, in a field like optimization, it is very common for folks to think of solutions as either purely machine learning or purely classical. I am a firm believer that we want to get the best of both worlds, and this is a really strong instantiation of that hybrid approach,” says senior author Cathy Wu, the Gilbert W. Winslow Career Development Assistant Professor in Civil and Environmental Engineering (CEE), and a member of a member of the Laboratory for Information and Decision Systems (LIDS) and the Institute for Data, Systems, and Society (IDSS). Wu wrote the paper with co-lead authors Siriu Li, an IDSS graduate student, and Wenbin Ouyang, a CEE graduate student; as well as Max Paulus, a graduate student at ETH Zurich. The research will be presented at the Conference on Neural Information Processing Systems. Tough to solve MILP problems have an exponential number of potential solutions. For instance, say a traveling salesperson wants to find the shortest path to visit several cities and then return to their city of origin. If there are many cities which could be visited in any order, the number of potential solutions might be greater than the number of atoms in the universe.   “These problems are called NP-hard, which means it is very unlikely there is an efficient algorithm to solve them. When the problem is big enough, we can only hope to achieve some suboptimal performance,” Wu explains. An MILP solver employs an array of techniques and practical tricks that can achieve reasonable solutions in a tractable amount of time. A typical solver uses a divide-and-conquer approach, first splitting the space of potential solutions into smaller pieces with a technique called branching. Then, the solver employs a technique called cutting to tighten up these smaller pieces so they can be searched faster. Cutting uses a set of rules that tighten the search space without removing any feasible solutions. These rules are generated by a few dozen algorithms, known as separators, that have been created for different kinds of MILP problems.  Wu and her team found that the process of identifying the ideal combination of separator algorithms to use is, in itself, a problem with an exponential number of solutions. “Separator management is a core part of every solver, but this is an underappreciated aspect of the problem space. One of the contributions of this work is identifying the problem of separator management as a machine learning task to begin with,” she says. Shrinking the solution space She and her collaborators devised a filtering mechanism that reduces this separator search space from more than 130,000 potential combinations to around 20 options. This filtering mechanism draws on the principle of diminishing marginal returns, which says that the most benefit would come from a small set of algorithms, and adding additional algorithms won’t bring much extra improvement. Then they use a machine-learning model to pick the best combination of algorithms from among the 20 remaining options. This model is trained with a dataset specific to the user’s optimization problem, so it learns to choose algorithms that best suit the user’s particular task. Since a company like FedEx has solved routing problems many times before, using real data gleaned from past experience should lead to better solutions than starting from scratch each time. The model’s iterative learning process, known as contextual bandits, a form of reinforcement learning, involves picking a potential solution, getting feedback on how good it was, and then trying again to find a better solution. This data-driven approach accelerated MILP solvers between 30 and 70 percent without any drop in accuracy. Moreover, the speedup was similar when they applied it to a simpler, open-source solver and a more powerful, commercial solver. In the future, Wu and her collaborators want to apply this approach to even more complex MILP problems, where gathering labeled data to train the model could be especially challenging. Perhaps they can train the model on a smaller dataset and then tweak it to tackle a much larger optimization problem, she says. The researchers are also interested in interpreting the learned model to better understand the effectiveness of different separator algorithms. This research is supported, in part, by Mathworks, the National Science Foundation (NSF), the MIT Amazon Science Hub, and MIT’s Research Support Committee.

Mary Cleave, NASA’s Pioneering Astronaut and Scientist, Dies at 76

Mary Cleave, a pioneering NASA astronaut who embarked on two spaceflights and later became the first woman to lead NASA’s Science Mission Directorate, has passed...

Retired NASA astronaut Mary Cleave, known for her two spaceflights and leadership in NASA’s Science Mission Directorate, has died at 76. Her notable achievements include the Magellan Venus mission and numerous NASA awards. (Official NASA portrait of astronaut Mary L. Cleave.) Credit: NASA Mary Cleave, a pioneering NASA astronaut who embarked on two spaceflights and later became the first woman to lead NASA’s Science Mission Directorate, has passed away at 76. She made significant contributions to space exploration, including the deployment of the Magellan Venus spacecraft, and received multiple awards for her service. Retired NASA astronaut Mary Cleave, a veteran of two NASA spaceflights, died November 27. She was 76. A scientist with training in civil and environmental engineering, as well as biological sciences and microbial ecology, Cleave was the first woman to serve as an associate administrator for NASA’s Science Mission Directorate. Born in Southampton, New York, Cleave received a Bachelor of Science degree in biological sciences from Colorado State University, Fort Collins, in 1969, and Master of Science in microbial ecology and a doctorate in civil and environmental engineering, both from Utah State University, Logan, in 1975 and 1979, respectively. “I’m sad we’ve lost trailblazer Dr. Mary Cleave, shuttle astronaut, veteran of two spaceflights, and first woman to lead the Science Mission Directorate as associate administrator,” said NASA Associate Administrator Bob Cabana. “Mary was a force of nature with a passion for science, exploration, and caring for our home planet. She will be missed.” Former NASA astronaut Mary Cleave speaks during an astronaut panel discussion at the 70th International Astronautical Congress, Friday, Oct. 25, 2019, at the Walter E. Washington Convention Center in Washington. Credit: NASA/Aubrey Gemignani) Cleave was selected as an astronaut in May 1980. Her technical assignments included flight software verification in the SAIL (Shuttle Avionics Integration Laboratory), spacecraft communicator on five space shuttle flights, and malfunctions procedures book and crew equipment design. Cleave launched on her first mission, STS-61B, aboard space shuttle Atlantis on November 26, 1985. During the flight, the crew deployed communications satellites, conducted two six-hour spacewalks to demonstrate space station construction techniques, operated the Continuous Flow Electrophoresis experiment for McDonnell Douglas and a Getaway Special container for Telesat and tested the Orbiter Experiments Digital Autopilot. The crew assigned to the STS-61B mission included (kneeling left to right) Bryan D. O’conner, pilot; and Brewster H. Shaw, commander. On the back row, left to right, are Charles D. Walker, payload specialist; mission specialists Jerry L. Ross, Mary L. Cleave, and Sherwood C. Spring; and Rodolpho Neri Vela, payload specialist. Credit: NASA Cleave’s second mission, STS-30, which also was on Atlantis, launched May 4, 1989. It was a four-day flight during which the crew successfully deployed the Magellan Venus exploration spacecraft, the first planetary probe to be deployed from a space shuttle. Magellan arrived at Venus in August 1990 and mapped more than 95% of the surface. In addition, the crew also worked on secondary payloads involving indium crystal growth, electrical storms, and Earth observation studies. Cleave transferred from NASA’s Johnson Space Center in Houston to the agency’s Goddard Space Flight Center in Greenbelt, Maryland in May 1991. There, she worked in the Laboratory for Hydrospheric Processes as the project manager for SeaWiFS (Sea-viewing, Wide-Field-of-view-Sensor), an ocean color sensor that monitored vegetation globally. Moments after ignition, Space Shuttle Atlantis heads for a four-day mission in Earth-orbit with five astronaut crew members aboard. Onboard were astronauts David M. Walker, Ronald J. Grabe, Norman E. Thagard, Mary L. Cleave, and Mark C. Lee. Launch occurred at 2:46:58 p.m. (EDT), May 4, 1989. Credit: NASA In March 2000, she went to serve as deputy associate administrator for advanced planning in the Office of Earth Science at NASA’s Headquarters in Washington. From August 2005 to February 2007, Cleave was the associate administrator for NASA’s Science Mission Directorate where she guided an array of research and scientific exploration programs for planet Earth, space weather, the solar system, and the universe. She also oversaw an assortment of grant-based research programs and a diverse constellation of spacecraft, from small, principal investigator-led missions to large flagship missions. Cleave’s awards included: two NASA Space Flight medals; two NASA Exceptional Service medals; an American Astronautical Society Flight Achievement Award; a NASA Exceptional Achievement Medal; and NASA Engineer of the Year. Cleave retired from NASA in February 2007.

These Male Stick Insects Aren't 'Errors' After All

Some female stick insects can reproduce without males—but they have a secret

December 1, 20232 min readThese Male Stick Insects Aren’t ‘Errors’ After AllSome female stick insects can reproduce without males—but they have a secretBy Saugat BolakheTimema poppense, a species related to the stick insects studied in the new work. Credit: Moritz Muschick/University of SheffieldCertain wingless, sticklike insects that hide in bushes and trees across central California have no need for males: these insects in the Timema genus are nearly all female and reproduce without sex by creating genetic clones of themselves, a process called parthenogenesis.But entomologists occasionally stumble on male Timema insects, which seem to have no reproductive function. “We initially assumed that the males were just errors, as loss of a single X chromosome can result in an egg developing into a male,” says ecologist Susana Freitas, who led the study while working at the University of Lausanne in Switzerland.Freitas and her team found that the uncommon males may engage in infrequent flings with the females. This “cryptic sex” introduces genetic diversity into stick insect populations and might aid their long-term survival. The team's genetic analysis was recently published in the Proceedings of the Royal Society B.Parthenogenesis (meaning “virgin birth”) is common among invertebrates and even occurs in some species of birds, lizards and snakes. For some, it's a last resort when mating options are limited; for others, it's their only method of reproduction. But creating offspring through cloning results in low genetic diversity, leaving a population vulnerable to harmful mutations and limiting its ability to adapt to environmental changes.To examine the genetic diversity of the stick insects, researchers extracted DNA from females and rare males in eight Timema populations across four species. They then tracked the position of various genetic markers in each insect. These markers stay linked on chromosomes during asexual reproduction but are reshuffled with another individual's genes during sexual reproduction.Most offspring genetically resembled their female parents. But offspring in two Timema species showed greater genetic diversity and fewer linked genes, indicating cryptic sexual relations. Tellingly, the genetic profiles of the uncommon males matched what would be expected from a rare sexual encounter.The discovery “reinforces the hypothesis that many of the species previously thought to be anciently asexual in fact engage in sexual reproduction or other forms of genetic exchange,” says Olga Vakhrusheva, an evolutionary biologist at the Skolkovo Institute of Science and Technology in Moscow, who was not involved in the new work.These rare interactions, also known to occur among small crustaceans and water invertebrates, “could be helping to wash away any deleterious mutations,” says Alexis L. Sperling, a crop scientist at the University of Cambridge, who also was not involved in the new study. She notes that many agricultural pests such as aphids, wasps and flies reproduce asexually. Cryptic sex or similar strategies could help these pests thrive, Sperling suggests— “but we need more research to be sure.”

The ancient origins of cannabis and our changing attitudes towards it

Cannabis attitudes are undergoing a seismic shift but what do really know about the drug? Our three-part special podcast series is uncovering the science of marijuana

Cannabis related items on display at Housing Works, New York’s first legal cannabis dispensaryErik Pendzich/Shutterstock Cannabis is having a moment. Half of Americans live in a state with legal marijuana and 9 in 10 people nationwide support legalisation in some form. This is a stark difference from mere decades ago, when prohibition was the norm in the entire US. Meanwhile, if you live in Malta, Uruguay, Canada – and maybe soon, Germany – your entire country is one with legal recreational pot. And access to medical marijuana extends to even more countries, including the UK and Australia. But as medical and recreational use become more popular and increasingly accessible, how exactly did we get to this moment of change? What has research been able to tell us – so far – about how the plant produces its euphoric effects, or what medical purposes it may be able to serve or how it might be harmful? And how could our relationship with this unassuming leaf change in coming decades? In the first episode of a special 3-part podcast series, Christie Taylor and the rest of the New Scientist reporting team start at the beginning: 27.8 million years ago, when hops and hemp diverged in family Cannabaceae. A million years ago, when Cannabis indica and Cannabis sativa diverged into two differently psychoactive strains. And 12,000 years ago, when humans first domesticated cannabis for mundane household use, not yet dreaming of the euphoric experiences to come. But of course, it all comes back to the high, and we go there too – the evidence, though still sparse, of drug-related use dating back at least to 500 BC. And, a thousand years later, perhaps the first recorded reference to a ritual not unlike hotboxing. To listen, subscribe to New Scientist Weekly or visit our podcast page. The science of cannabis As the use of marijuana and its compounds rises around the world, New Scientist explores the latest research on the medical potential of cannabis, how it is grown and its environmental impact, the way cannabis affects our bodies and minds and what the marijuana of the future will look like. Transcript Christie Taylor: It’s a sunny November morning in Manhattan and I’m buying weed for my job. Sasha Nugent: So right now, we have pre-rolls, tinctures, flower, edibles, and drinks, and that’s an array of things that we have. Vapes as well. We have flower and we offer it in eighth and one ounces, and we even have a three ounce bag, and three ounce is the max in New York that you’re able to purchase in a day. Christie Taylor: That’s Sasha Nugent. She’s the so-called ‘Budmaster’ at Housing Works Cannabis Co. It’s the retail extension of a local AIDS non-profit and also the first recreational dispensary to be licensed in New York City, and if you’ve never been inside a licensed dispensary before, you may be shocked at how normal a retail experience it feels like. Two big display cases wrap around the retail area filled with colourful packages of merchandise, like gummies infused with THC, the main ingredient that gets people high, or CBD, a secondary ingredient that seems to have a more calming, chill effect. Pastel rainbow signs next to the row of cash registers have slogans like ‘make love, not drug war’, and ‘spark up your inner activist’, and ‘we’re smoking out stigma’. The product labels range from slightly goofy and psychedelic to what I can only describe as a colourful fruit salad, and for the Apple Store types, there’s sleek and minimalist black and white packaging. Sasha Nugent: On a slow day, anywhere from, like, Sunday to Wednesday, we see about 550 to 700 people depending on the day. On our busier days, Thursday through Saturday, we can see upwards of 1,000 unique customers. Christie Taylor: The normality of this experience has only become possible recently. New York State only legalised recreational cannabis in 2021. Other states went sooner and there has been a dramatic wave of various degrees of legalisation across the US, and even across the world. We are in a new normal when it comes to cannabis, but what do we really know about the science of it? Where did the plant come from? What does it do to our health, for good or for bad? I’m Christie Taylor. I’m a podcast producer for New Scientist, and this is the first episode in our three-part series about the science of cannabis, how we got here, what we know, and what the future may hold. This is part of a huge month-long reporting effort from more than half a dozen journalists and you can read their work over at newscientist.com/cannabis. We’ve investigated cannabis and creativity, mapped the still languishing landscape of medical research, and questioned the environmental cost of industrial scale hemp harvests, but today I’m starting at the beginning, how we got to this moment where I can walk into a store, buy a federally controlled substance, and just tell you about it, and why our relationship with cannabis is possibly one of the oldest relationships our species has had with a domesticated plant.  If you want to feel really old, it’s been 87 years since the movie Reefer Madness debuted. It’s a hyperbolic fictional warning about young people driven to psychosis with multiple murders and deaths all because they had some weed. ‘These high school boys and girls are having a hop at the local soda fountain, innocent of a new and deadly menace lurking behind closed doors.’ (Advert played 03.25-03.32). But now, walk through many neighbourhoods in New York City and you’ll see something you didn’t used to, storefront after storefront with names like ‘Magic Garden’, ‘Smacked Village’, ‘Weed World’, or just ‘Gotham’. The fonts run from cartoonish to classy, and storefront signs, as in other cities with legal recreational and medical weed, will advertise under no uncertain circumstances that they have THC, CBD, or just the unmistakeable green seven-pointed leaf shape that screams ‘marijuana’. In states with legal cannabis, medical or otherwise, you can speak frankly with salespeople about dosages and strains. Do you want help sleeping, or daytime relaxation, pain or appetite management, or a sense of calm while getting your work done? Or do you just want to get stoned off your ass, watch some dumb TV, and laugh uncontrollably while making up new words for hedgehog? No judgement. No, really. Please, no judgement. Sasha Nugent: I am just like you. I have trouble sleeping and I also have anxiety, so after, like, a day at work, I love the Offline from Off Hours. Like, they don’t pay me. That’s one of my favourite ones. Christie Taylor: Outside the dispensaries, at corner stores and bodegas, you can still buy THC-infused seltzers and mocktails, cannabis cocktails, and skin lotions featuring CBD. In states like Wisconsin that haven’t legalised cannabis, purveyors get around it with a less potent form of THC called Delta-8. It’s derived from non-psychoactive cannabis and so remains, for now, legal in the US through a loophole in a 2018 agriculture law. Some of the greater glow of legality is in the name of medical applications, which are very real but still under investigation in the case of some treatments. In states where weed is legal only in medical contexts, your doctor can still usually get you a dispensary card for ALS, Parkinson’s disease, chronic pain, cancer and chemo side effects, and mental health conditions like PTSD, and the number of people enrolled in medical marijuana programmes in the US? It more than quadrupled between 2016 and 2020 to a whopping 3 million. People use it for nausea, pain, and glaucoma symptoms. It’s showing legitimate promise as a treatment for multiple sclerosis and rare forms of epilepsy, but when we look at this moment in our relationship with cannabis, it’s also clear that the years of prohibition have cost us research. Because the US federal government still bans weed, scientists have struggled for funding, or simply a sufficient legal supply to study.  The late Dr. Raphael Mechoulam, the Israeli scientist who first isolated THC from cannabis in the 1950s, he even had to get his first samples from the police, and as its therapeutic potential gains greater excitement, the federal ban on weed is still undermining scientific research that might bring clarity on both the benefits and the risks of its consumption. This research is needed more than ever. At Housing Works, I’m presented with three seemingly equal products, gummy edibles, that might help me sleep better. They all advertise their properties in terms of milligrams of THC and other calming compounds, so I pick one called Snoozeberry solely by the promise that it would taste like blueberry, a flavour I liked, and I’m charmed maybe just a little bit by the twinkling stars on the soothing deep blue packaging. Sasha Nugent: Perfect. So this is your receipt, and would you like a bag? Christie Taylor: Yes, I’ll take a bag. Sasha Nugent: No problem. I’ll grab one for you. Christie Taylor: Okay. Sasha Nugent: So we also offer delivery, so I put a delivery flyer in case you’re in one of our delivery zones, and I also put a little sticker with our QR code in case you want to order it in advance. Christie Taylor: Alright. Thank you so much. Sasha Nugent: Thank you so much. It was great meeting you. Christie Taylor: Yes, great meeting you too. You’re not high. A revolution has been baking toward the popularity and acceptance of weed. Legalisation of cannabis for recreational use has swung hugely into favour in the last 10 years. Uruguay legalised recreational use of marijuana in 2013, Canada in 2018, Malta 2021. Lawmakers in Germany may soon vote on a bill to do the same, and medical marijuana is even more widely legalised, including in the UK and Australia. In the US, there’s no national approval of cannabis in any context. Instead, it’s a state by state patchwork, but one that is increasingly pro-pot, with 38 states and Washington, DC all moving to legalise marijuana. Nearly half of those are states that support both medical and recreational use, including, just weeks ago, the state of Ohio, and if you ask we, the people, there’s overwhelming support for national legalisation. Nearly 7 in 10 Americans say ‘yes’. Alexis Wnuk: That’s actually triple what it was 30 years ago. Christie Taylor: New Scientist’s Alexis Wnuk dug into the data explaining this shift and she found the swing in attitudes is even more dramatic than that. Alexis Wnuk: So if you ask people specifically about recreational and medical uses, it’s more like 9 in 10 people in favour of legalising it in some capacity. Younger people and those on the political left continue to support legalisation in greater numbers than older people and people on the political right, but we’ve seen a surge in support across all age groups and the entire political spectrum. Christie Taylor: Republican support, while still quite a bit lower than other groups, tripled between 1990 and 2016. This also seems to align with a shift in how people perceive the dangers of cannabis. For the 50 years that the US has tracked these perceptions, people have always seen cannabis as less dangerous than drugs like cocaine or heroin, but in the early 2000s, that gap got even bigger. Alexis Wnuk: Around 20% of people surveyed in 1997 said that smoking marijuana once or twice a week posed minimal or no risk of harm, but by 2021, which is the most recent data we have, half of people surveyed thought this, and we know this wasn’t just because perceptions of all drugs were changing, because people still ranked other drugs at about the same level of danger as they did 30 years ago. Christie Taylor: So why have people swung so comparatively hard for cannabis in recent decades? The biggest reason is medical marijuana. If you look back at the surveys, 98% of people who supported legalisation said that medical use was a very important or somewhat important reason why. Alexis Wnuk: In the 1980s and ’90s, we started seeing studies that suggested cannabis could reduce nausea and improve appetite in people with HIV (TC 00:10:00) and in those undergoing chemotherapy for cancer, and this started creeping into the national conversation on marijuana. I came across a study from 2019 by researchers at John Jay College here in New York City where they tracked media coverage of marijuana over the years. They took the New York Times, one of the most read newspapers in the nation, as a case study, and what they found was that in the late ’90s, articles about medical use of cannabis started making up more and more of the coverage. At the same time, there’s less and less coverage dealing with marijuana trafficking or abuse. Christie Taylor: Headlines about multimillion-dollar pot busts declined. You were more likely to see stories like the 1993 headline about a 79 year old woman who was growing weed to help her son, who had multiple sclerosis, eat better, or a pot-smoking club in San Francisco reserved for the sick and dying. 1996 is also when you saw California become the first state to allow cannabis for medicinal purposes with a doctor’s supervision. Alexis Wnuk: Obviously, we can’t know for sure whether the media coverage actually changed people’s attitudes or whether it was just following the shift in attitudes but what we do know is that, in this time period, we saw a big uptick in coverage of medical marijuana and the people who could benefit from it, so instead of fearmongering and crime, you were much more likely to see a focus on compassionate use for people who were critically ill. Christie Taylor: There are a lot of other reasons ranking highly as well. Nearly as important for some people was freeing up law enforcement to do other work, followed by the argument that it’s someone’s personal choice to consume it. Deeper in the survey data, there’s support for the argument that tax revenue from legal weed could support local governments, or that it just might be safer to have legal oversight for weed, and if you go back to the perceptions of risk, there were people that said that using weed is already safe and so there’s no reason to outlaw it. Half of Americans now live in a state with legal recreational cannabis and there’s no sign that the wave is slowing down. The thing is, the weed zeitgeist, this wave of stigma oscillating into mania, isn’t the first time that our species has used this plant, whether for highs or healing. It’s one of the first crops human beings ever cultivated, starting 12,000 years ago. Think the oldest profession but make it agriculture, and until 100 years ago, it was one of our species most important sources of fibre, shelved only thanks to the rise of synthetic fibres such as nylon, but what was cannabis doing before humans met hemp? First, we should also talk about humulus, marijuana’s cousin in family Cannabaceae. You know it as hops, which flavours our beer, but fossils of the two plants have been confused for each other numerous times over the years, which is why genetics may be the better arbiter of when hops and herb diverted in the evolutionary tree. The evolution of plants like cannabis is hard to study. You need fossils, and soft matter doesn’t make the same impressions in stone that bones or teeth might, but the traces do exist and modern genomic science is also increasingly helping us use living plants to scry backward in time. It’s a kind of timekeeping that relies on mutations. A molecular clock. Scientists can count how many mutations the two plants have gathered over time and use that to determine that hops and cannabis diverted into separate species around 27.8 million years ago. Hops went on to become a funky-smelling climbing plant integral to beer but not particularly psychoactive on its own, but cannabis? It’s a funky-smelling, wind-pollinated, herbaceous ground plant that’s rich in oils and protein. It gets you high and it slows you down, and as fossil pollen indicates, it may have originally evolved on the Tibetan plateau at dizzying elevations with an arid climate and harsh, inhospitable levels of UV radiation from the Sun. Chelsea Whyte tracked down this high-elevation history. Chelsea Whyte: This also may be why the plant possesses its calming properties. THC and CBD, as well as other cannabinoids, seem to protect plants from UV rays, and cannabis may have developed these compounds as an adaptation to its early habitat. Christie Taylor: And then there’s the question of cannabis sativa and cannabis indica. Seasoned pot consumers know these two psychoactive species of cannabis can feel very different in the body and brain but the fact that you can be discerning down to the level of Latin names might not have anything to do with human husbandry. The same molecular clock method of genetic analysis shows that indica and sativa diverged more than 1 million years ago, back when our distant ancestor, homo habilis, was hunting on the plains of Africa. Chelsea Whyte: We’d had tools for about 1.5 million years at that point. That’s what homo habilis was known for, but we haven’t found any evidence for those long ago ancestors consuming cannabis in any way, nor is there evidence that cannabis had particularly high levels of THC at the time, so while it’s fun to wonder if there were Stone Age stoners, there’s no actual sign of it. Christie Taylor: What we do find is evidence of human cultivation 12,000 years ago in East Asia, by people who seemed to use the plant for ordinary household needs. Oil, rope, bow strings. We know this because while the original wild strain we started with may be extinct, it’s closest living relative seems to be in Northwest China and the genomic record matches the archaeological. There’s pottery that’s been marked by hemp cords dating from the same millennium, for example, and once we began to cultivate cannabis, it spread, and spread, and spread. Chelsea Whyte: It’s almost cliché at this point to say there’s a reason it’s called weed because it flourishes in a wide variety of conditions and doesn’t need too much tending. Whenever groups of people exchanged goods with others, cannabis went too. Farmers, trade, conquest, you name it. Christie Taylor: It started about 5,000 years ago when the Yamnaya people migrated from the Eurasian Steppe and brought cannabis to parts of Europe and the Middle East. A thousand years later, pot entered Korea through trade with China, and South Asia via Indo-Aryan peoples migrating from central Asia. Chelsea Whyte: Around 2000 BC, the western Eurasian Steppe was home to a nomadic people called the Scythians, and they carried it on horseback from the Middle East to what is now Russia and Ukraine. Christie Taylor: Germanic tribes took it west to Britain as the Anglo-Saxons conquered. It was in Northern Africa by 1400 AD and spread from there to the southern tip, and then, as European colonialism so well facilitated, cannabis crossed the Atlantic and spread across North and South America. We’ll talk more in a future episode about the current state of medical uses of cannabis and what we know about them. At the moment, the earliest evidence of therapeutic use dates back to a Chinese shaman who was buried with a stash of cannabis sativa in 700 BC, but medical records suggest people have been trying to heal with cannabis for thousands of years, starting 5,000 years ago in the reign of Chinese emperor Shennong. He claimed cannabis could cure a wide range of ailments such as malaria, menstrual problems, and gout, and maybe paradoxically, he prescribed it for absent-mindedness as well. Western doctors weren’t using cannabis until much more recently, the late 19th and early 20th century, when one of Queen Victoria’s doctors used the plant to treat a wide variety of pain-related illnesses, including some of her premenstrual symptoms. The drug was even listed in the US Pharmacopeia, the country’s official compendium of medical drug information, but then it was outlawed in 1942, decades into a rising crackdown and prohibition of the plant. We wouldn’t come full circle again until 1996, when California residents passed Proposition 215 and made medical marijuana legal again. So when, you ask, did we start getting stoned? Was it the Stone Age or was it much later? Was there a single moment when early humans inhaled some skunky sativa smoke and realised they felt pretty dope about it? Chelsea Whyte: The evidence here is pretty spotty but we know that wild cannabis plants have only trace amounts of the psychoactive compounds that get us giddy, including THC and CBD, so researchers have looked for evidence of plants with higher concentrations which we would have had to cultivate specifically. Christie Taylor: We have a long, long history with this plant but only 4,000 years ago do we start to see the evidence of humans nurturing specific strains for specific purposes, whether for fibre or drugs. Chelsea Whyte: You can actually see in the way different strains diverge what uses they were bred for. Those bred for fibre have more gene mutations that inhibit the stems from branching out, so they have taller stems and more fibre in the main stem, but the plants that were bred for drug use have mutations supporting more branching, which also means more flowers. Those plants are shorter but they also tend to have more THC. Christie Taylor: Beyond Emperor Shennong’s medicinal mention 4,500 years ago, the first trace of toking only emerged in 2019 in the mountains of Western China. Researchers exploring ancient tombs found wooden fire pits called braziers with traces of THC at much, much higher concentrations than in wild cannabis. These date back to 500 BC, 2,500 years ago, and they suggest that people at that time were inhaling the potent smoke of a strain of cannabis that they had cultivated specifically for the high, but instead of the joints, pipes or bongs you may be familiar with, these braziers would likely have been filled with red hot pebbles that the cannabis was then put on top of. The smoke from the smouldering plant could then be inhaled. And remember those Scythians marauding through Russia and Ukraine on horseback? The Greek geographer and historian Herodotus, writing in the 5th century AD, describes a ritual that may be the first recorded instance of hotboxing. Herodotus: ‘They set up three poles leaning together to a point, and cover these over with woollen mats. Then, in the place so enclosed, to the best of their power, they make a pit in the centre beneath the poles and the mats, (TC 00:20:00) and throw red hot stones into it. The Scythians then take the seed of this hemp and, creeping under the mats, they throw it on the red hot stones, and being so thrown, it smoulders and sends forth so much steam that no Greek vapour bath could surpass it. The Scythians howl in their joy at the vapour bath.’ Christie Taylor: So weed has been with us for 12,000 years and we’ve found it at least some level of therapeutic for 4,500 of those years. People have used, and continue to use, it for physical ailments, emotional balm, and a certain mental letting loose, but as the wave of cannabis legalisation in the US and worldwide gathers momentum, what do we actually know about how it affects us, body and brain? Stay tuned for the next episode where we’ll look at what happens to your brain on drugs, and what the past prohibitions on pot have done to limit our knowledge of how it behaves, even as the need for that knowledge is greater than ever.  As I mentioned earlier, this podcast is part of a massive reporting effort, spanning many months of work from the New Scientist team. You can go to newscientist.com/cannabis to read much, much more about the history of our relationship with weed and what research is starting to reveal. Thanks to Chelsea Whyte, Alexis Wnuk, and Grace Wade for helping me research and write this episode, and to Timothy Revell and Chelsea Whyte for edits. Thanks also to Timothy Revell for his expert voice acting. New York studio production is by Hugo Fonseca, and our audio and sound design is by Ollie Guillou. I’m Christie Taylor. Bye for now.

MIT’s Science Policy Initiative holds 13th annual Executive Visit Days

MIT students traveled to Washington to speak to representatives from several federal executive agencies.

From Oct. 23-24, a delegation consisting of 21 MIT students, one MIT postdoc, and four students from the University of the District of Columbia met in Washington for the MIT Science Policy Initiative’s Executive Visit Days (ExVD). Now in its 13th cycle, this trip offers a platform where university students and young researchers can connect with officials and scientists from different federal agencies, discuss issues related to science and technology policy, and learn about the role the federal government plays in addressing these issues. The delegation visited seven different agencies, as well as the MIT Washington Office, where the group held virtual calls with personnel from the National Institutes of Health and the Advanced Research Projects Agency for Health. Visits to the National Science Foundation, Department of Energy Office of Science, White House Office of Science and Technology Policy (OSTP), Environmental Protection Agency, and National Aeronautics and Space Administration then followed over the course of two days. The series of meetings, facilitated by the MIT Science Policy Initiative (SPI), offered a window into the current activities of each agency and how individuals can engage with science policy through the lens of each particular agency. The Science Policy Initiative is an organization of students and postdocs whose core goal is not only to grow interest at MIT and in the community at large in science policy, but also to facilitate the exchange of ideas between the policymakers of today and the scientists of tomorrow. One of the various trips organized by SPI every year, ExVD allows students to gain insight into the work of federal agencies, while also offering the chance to meet with representatives from these agencies, many of whom are MIT alumni, and discuss their paths toward careers in science policy. Additionally, ExVD serves as an opportunity for participants to network with students, postdocs, and professionals outside of their fields but united by common interests in science policy.  “I believe it is critical for students with vital technical expertise to gain a sense of the realities of policymaking,” says Phillip Christoffersen, a PhD student researching AI in MIT’s Department of Electrical Engineering and Computer Science and SPI ExVD 2023 chair. “Due to the many complexities of modern life, we are simultaneously reaching tipping points in many fields — AI, climate change, biotechnology, among many others. For this reason, science and science policy must increasingly move in lockstep for the good of society, and it falls on us as scientists-in-training to make that happen.” One example of the delegation’s visits was to the White House OSTP, located directly next to the West Wing at the Eisenhower Executive Office Building. This special agency of fewer than 200 staff, most of whom are either in rotation or on loan from other federal agencies, directly reports to the president on all matters related to science and policy. The atmosphere at the White House complex and the exchanges with Kei Koizumi, principal deputy director for policy at OSTP, deeply inspired the students and showcased the vast impact science can have on federal policy. The overall sentiment among the ExVD participants has been that of reborn motivation, having become inspired to participate in policy matters, either as a portion of their graduate research or in their future career. The ExVD 2023 cohort is thankful to the MIT Washington office, whose generous support was crucial to making this trip a reality. Furthermore, the delegation thanks the MIT Science Policy Initiative’s leadership team for organizing this trip, enabling an extremely meaningful experience.

Suggested Viewing

Join us to forge
a sustainable future

Our team is always growing.
Become a partner, volunteer, sponsor, or intern today.
Let us know how you would like to get involved!

CONTACT US

sign up for our mailing list to stay informed on the latest films and environmental headlines.

Subscribers receive a free day pass for streaming Cinema Verde.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.